Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Reiter

Showing results (111-120 of 386) with videos related to

Pageof 39
Sort By:
American Journal of Clinical Oncology|August 4, 2015
Wrong to be Right: Margin Laterality is an Independent Predictor of Biochemical Failure After Radical ProstatectomyJung J Kang, Robert E Reiter, Nicolas Kummer, et al.
Urologic Oncology|March 11, 2009
The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancersHervé Wallerand, Grégoire Robert, Gilles Pasticier, et al.
Biochemical and Biophysical Research Communications|April 7, 1997
Luteinizing hormone increases the abundance of various transcripts, independently of the androgens, in the rat prostateE Reiter, J Poncin, B Hennuy, et al.
The Prostate|February 11, 1999
Effects of pituitary hormones on the prostateE Reiter, B Hennuy, M Bruyninx, et al.
The Journal of Urology|May 29, 2003
Immunocytochemical analysis of prostate stem cell antigen as adjunct marker for detection of urothelial transitional cell carcinoma in voided urine specimensLirong Cheng, Robert E Reiter, Yusheng Jin, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1993
Benign prostatic hyperplasia and normal prostate aging: differences in types I and II 5 alpha-reductase and steroid hormone receptor messenger ribonucleic acid (mRNA) levels, but not in insulin-like growth factor mRNA levelsP Bonnet, E Reiter, M Bruyninx, et al.
The Journal of Urology|February 22, 2008
The influence of cardiovascular disease on health related quality of life in men with prostate cancer: a 4-year followup studyLonneke V van de Poll-Franse, Lorna Kwan, Robert E Reiter, et al.
Nano Letters|November 23, 2021
Electron Dynamics in a Two-Dimensional Nanobubble: A Two-Level System Based on Spatial DensityRoberto Rosati, Frank Lengers, Christian Carmesin, et al.
Brachytherapy|February 8, 2007
Improvements in prostate brachytherapy dosimetry due to seed strandingKevin Lin, Steve P Lee, Jennifer S Cho, et al.
The Prostate|June 4, 2013
Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell linesDaniel Seiler, Junying Zheng, Gentao Liu, et al.
Pageof 39

Showing results (111-120 of 386) with videos related to

Sort By:
Pageof 39
American Journal of Clinical Oncology|August 4, 2015
Wrong to be Right: Margin Laterality is an Independent Predictor of Biochemical Failure After Radical ProstatectomyJung J Kang, Robert E Reiter, Nicolas Kummer, et al.
Urologic Oncology|March 11, 2009
The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancersHervé Wallerand, Grégoire Robert, Gilles Pasticier, et al.
Biochemical and Biophysical Research Communications|April 7, 1997
Luteinizing hormone increases the abundance of various transcripts, independently of the androgens, in the rat prostateE Reiter, J Poncin, B Hennuy, et al.
The Prostate|February 11, 1999
Effects of pituitary hormones on the prostateE Reiter, B Hennuy, M Bruyninx, et al.
The Journal of Urology|May 29, 2003
Immunocytochemical analysis of prostate stem cell antigen as adjunct marker for detection of urothelial transitional cell carcinoma in voided urine specimensLirong Cheng, Robert E Reiter, Yusheng Jin, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1993
Benign prostatic hyperplasia and normal prostate aging: differences in types I and II 5 alpha-reductase and steroid hormone receptor messenger ribonucleic acid (mRNA) levels, but not in insulin-like growth factor mRNA levelsP Bonnet, E Reiter, M Bruyninx, et al.
The Journal of Urology|February 22, 2008
The influence of cardiovascular disease on health related quality of life in men with prostate cancer: a 4-year followup studyLonneke V van de Poll-Franse, Lorna Kwan, Robert E Reiter, et al.
Nano Letters|November 23, 2021
Electron Dynamics in a Two-Dimensional Nanobubble: A Two-Level System Based on Spatial DensityRoberto Rosati, Frank Lengers, Christian Carmesin, et al.
Brachytherapy|February 8, 2007
Improvements in prostate brachytherapy dosimetry due to seed strandingKevin Lin, Steve P Lee, Jennifer S Cho, et al.
The Prostate|June 4, 2013
Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell linesDaniel Seiler, Junying Zheng, Gentao Liu, et al.
Pageof 39